Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Terns Pharmaceuticals Inc shares valued at $3,640 were sold by Kuriakose Emil on Jul 01 ’25. At $4.27 per share, Kuriakose Emil sold 853 shares. The insider’s holdings dropped to 52,464 shares worth approximately $0.28 million following the completion of this transaction.
Also, Gengos Andrew purchased 10,000 shares, netting a total of over 39,283 in proceeds. Following the buying of shares at $3.93 each, the insider now holds 25,000 shares.
Before that, Burroughs Amy L. had added 23,314 shares to its account. In a trade valued at $90,230, the Chief Executive Officer bought Terns Pharmaceuticals Inc shares for $3.87 each. Upon closing the transaction, the insider’s holdings increased to 23,314 shares, worth approximately $0.25 million.
As published in their initiating research note from William Blair on February 28, 2025, Terns Pharmaceuticals Inc [TERN] has been a Mkt perform. Analysts at Oppenheimer started covering the stock with ‘”an Outperform”‘ outlook in a report released in late October. As of June 22, 2023, Mizuho has initiated its “Buy” rating for TERN. Earlier on June 07, 2023, Jefferies initiated its rating. Their recommendation was “a Buy” for TERN stock.
Analyzing TERN Stock Performance
On last trading session,, Terns Pharmaceuticals Inc [NASDAQ: TERN] rose 4.36% to $5.27. The stock’s lowest price that day was $5.08, but it reached a high of $5.28 in the same session. During the last five days, there has been a surge of approximately 7.77%. Over the course of the year, Terns Pharmaceuticals Inc shares have dropped approximately -43.39%. Shares of the company reached a 52-week high of $5.95 on 01/06/25 and a 52-week low of $1.87 on 04/07/25.
Support And Resistance Levels for Terns Pharmaceuticals Inc (TERN)
According to the 24-hour chart, there is a support level at 5.13, which, if violated, would cause prices to drop to 4.99. In the upper region, resistance lies at 5.35. The next price resistance is at 5.43. RSI (Relative Strength Index) is 73.37 on the 14-day chart, showing overbought technical sentiment.
Is Terns Pharmaceuticals Inc subject to short interest?
Stocks of Terns Pharmaceuticals Inc saw a sharp rise in short interest on 2025-06-13 jumping by 0.48 million shares to 5.94 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 5.46 million shares. A jump of 8.15% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 7.49 of the overall float, the days-to-cover ratio (short ratio) jumped to 7.49.
Which companies own the most shares of Terns Pharmaceuticals Inc (TERN)?
In terms of Terns Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 14 in the next 12 months, up nearly 177.23% from the previous closing price of $5.05. Analysts anticipate Terns Pharmaceuticals Inc stock to reach 26 by 2025, with the lowest price target being 7. In spite of this, 5 analysts ranked Terns Pharmaceuticals Inc stock as Buy at the end of 2025. On May 31, 2023, ROTH MKM assigned a price target of “a Buy” to the stock and initiated coverage with a $23.
